PHARMATEST E 300 - Pharmacom Labs

First described in the 1950 testosterone enanthate is a synthetic form of testosterone extensively used for hormone replacement therapy in men with testosterone deficiency.  The ester allows for an lasting release of the substance, into the body. This means fewer injections are needed compared to esters that act quickly. Originally developed by Schering, the first U.S. brand was Delatestryl®, created by Squibb and currently owned by Endo Pharmaceuticals. Outside the U.S., Testoviron® has been a prominent brand for over 50 years, now owned by Bayer. The advantages of testosterone enanthate comprise increased vitality levels and mood enhancement, as improved muscle preservation when cutting weight phases while having minimal estrogen related side effects that aid, in decreasing water retention.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about PHARMATEST E 300 by Pharmacom Labs, consult with your doctor or healthcare professional.